Bristol-Myers calls all 4.375% notes due 2016, 4.625% notes due 2021

By Tali Rackner

Norfolk, Va., May 5 – Bristol-Myers Squibb Co. plans to redeem all €500 million of its 4.375% senior notes due 2016 and €500 million of 4.625% senior notes due 2021, according to two notices.

The notes will be redeemed at par plus accrued interest on June 4.

As previously reported, proceeds from a new offering of €1.15 billion of senior unsecured notes will finance the transaction.

BNP Paribas, Goldman Sachs & Co., Merrill Lynch International and Morgan Stanley & Co. International plc are acting as joint bookrunning managers for the public offering, which is expected to close on May 5.

The Bank of New York Mellon is the fiscal agent for the redemption.

The biopharmaceutical company is based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.